Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
66.44 USD | +1.55% | -0.77% | -17.99% |
02:31pm | Barclays Adjusts Price Target on Gilead Sciences to $76 From $80 | MT |
Apr. 26 | TD Cowen Adjusts Price Target on Gilead Sciences to $85 From $90 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.99% | 81.58B | |
+26.07% | 661B | |
+26.74% | 566B | |
-6.73% | 352B | |
+19.43% | 332B | |
+3.48% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.32% | 145B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Morgan Stanley Cuts Price Target on Gilead Sciences to $80 From $83, Keeps Equalweight Rating